FDA Investigator Hoimay Chan
Hoimay Chan has conducted inspections on 37 sites in 1 countries as of 21 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
37
Last Inspection Date:
21 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Hoimay Chan:
Abby Lmozeke Baker,
Adam J Taylor,
Albert F Peacock, PhD,
Andrew A Leboeuf,
Angel F Colon,
Angel K Sandhu,
Anya Dlockett Evans,
Barbara A Rusin,
Barbara G Peoples,
Barbara T Carmichael,
Blondell W Johnson,
Bobbi J Miller,
Bryce A May,
Cara M Minelli,
Carol F Robinson,
Charles D Boison,
Christopher J Adams,
Cody D Rickman,
Colleen M Aspinwall,
Darla J Christopher,
Decarlos A Gomez,
Denise L Burosh,
Deniza Karacic,
Diane Hall,
Doretha M Tonkins,
Dylan R Jock,
Emily S Mcgann,
Erma Zaimova,
Esther A Ofori,
Evelyn Taha,
Gabryelle J Solverud,
Garrad R Poole,
Harry J Brewer,
Irina Gaberman,
Ivan E Reyes,
Jeanette L Mcginnis,
Jeanne J Chiu,
Jeanne J Thai,
Jennifer C Adams,
Jennifer C Johnson,
John Cook,
Judy Ellen Ciaraldi,
Kaarin M Slotte,
Kanaeko R Raverell,
Karan L Blum,
Karen L Kosar,
Kathleen B Swat,
Kelley L Clark,
Kelly D Moore,
Lauren E Blaser,
Lauren M Lilly, PhD,
Laurie A Haxel,
Laverne Puckett,
LCDR Ismael Olvera, IV,
LCDR Jennifer H Rhyu,
Lee Terry Moore,
Lisa R Jennings,
Lisa R Whitt,
Lura D Baquero,
Lura D Kelly,
Marc A Jackson, Jr,
Marlene L Davis,
Mary T Carden,
Merelynn Rhoten,
Michael A Blaine,
Mizanne E Lewis,
Monique S Frazier,
Myra K Casey,
Nancy L Neiger,
Patricia A Clark,
Patricia M Jacobs,
Randy L Clarida,
Richard T Riggie,
Robert M Tillman,
Ronda Rloyd Jones,
Rosia E Nesbitt,
Shelley H Beausoleil,
Susan M Miller,
Susan M North,
Thai D Truong,
Tracy J Washington,
Travis S Bradley,
Uruaku A Obasi,
William C Lubas,
William F Lagud, Jr,
Young M Yoon,
Yvonne C Wilkes
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more